Advances in the development of entry inhibitors for sialic-acid-targeting viruses

Heida, R., Bhide, Y. C., Gasbarri, M., Kocabiyik, Ö., Stellacci, F., Huckriede, A. L. W., Hinrichs, W. L. J. & Frijlink, H. W., jan-2021, In: Drug Discovery Today. 26, 1, blz. 122-137 16 blz.

Onderzoeksoutput › peer review

COVID-19 vaccination: the VOICE for patients with cancer

van der Veldt, A. A. M., Oosting, S. F., Dingemans, A-M. C., Fehrmann, R. S. N., GeurtsvanKessel, C., Jalving, M., Rimmelzwaan, G. F., Kvistborg, P., Blank, C. U., Smit, E. F., Lemmens, V. E. E. P., Hiltermann, T. J. N., Koopmans, M. P. G., Huckriede, A. L. W., Rots, N. Y., van Els, C. A. C. M., van Baarle, D., Haanen, J. B. A. G. & de Vries, E. G. E., 15-feb-2021, In: Nature Medicine. 2 blz.

Onderzoeksoutput › Academic › peer review

Human plasmacytoid dendritic cells at the crossroad of type I interferon-regulated B cell differentiation and antiviral response to tick-borne encephalitis virus

Etna, M. P., Signorazzi, A., Ricci, D., Severa, M., Rizzo, F., Giacomini, E., Gaggioli, A., Bekeredjian-Ding, I., Huckriede, A. & Coccia, E. M., 15-apr-2021, (E-pub ahead of print) In: PLoS Pathogens. 17, 4, 25 blz., e1009505.

Onderzoeksoutput › Academic › peer review

In vitro assessment of tick-borne encephalitis vaccine: Suitable human cell platforms and potential biomarkers

Signorazzi, A., Etna, M. P., Coccia, E. M. & Huckriede, A., 13-jan-2021, (E-pub ahead of print) In: ALTEX: Alternatives to Animal Experimentation.

Onderzoeksoutput › Academic › peer review

Characterization of humoral immune responses and degree of protection induced by influenza vaccine in cotton rats: Effects of low vaccine dose and single vs booster vaccination

Bhide, Y., Dong, W., Meijerhof, T., de Vries-Idema, J., Niesters, H. G. & Huckriede, A., 22-apr-2020, In: Immunity, inflammation and disease. 8, 3, blz. 279-291 13 blz.

Onderzoeksoutput › Academic › peer review